Research Articles | Page 17 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Management of higher risk myelodysplastic syndromes after hypomethylating agents failure: are we about to exit the black hole? Sep 2020 Expert Review of Hematology Myelodysplastic Syndromes (MDS)
Getting personal with myelodysplastic syndromes: is now the right time? Apr 2019 Expert Review of Hematology Myelodysplastic Syndromes (MDS)
Higher-risk myelodysplastic syndromes with del(5q): does the del(5q) matter? Mar 2020 Expert Review of Hematology Myelodysplastic Syndromes (MDS)
Management of aplastic anemia after failure of frontline immunosuppression Jul 2019 Expert Review of Hematology Aplastic Anemia
Novel therapeutic choices in immune aplastic anemia Sep 2020 F1000Research Aplastic Anemia
The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes May 2023 Frontiers in Oncology Aplastic Anemia
Targeting the Microenvironment in MDS: The Final Frontier Jul 2020 Frontiers in Pharmacology Myelodysplastic Syndromes (MDS)
Luspatercept in the treatment of lower-risk myelodysplastic syndromes Jan 2021 Future Oncology (London, England) Myelodysplastic Syndromes (MDS)
Is blood transfusion safe during the COVID-19 pandemic? Sep 2020 Future Science OA Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Immunosuppression and Growth Factors for Severe Aplastic Anemia: New Data for Old Questions May 2020 Haematologica Aplastic Anemia